New Delhi: Drugs Controller General of India (DCGI) has given Cipla approval to import Moderna's COVID-19 vaccine for restricted…
World Health Organization (WHO) cited insufficient data in rejecting the proposal of Serum Institute of India (SII), seeking extension of…
New Delhi: Pfizer has decided to withdraw the application for emergency use authorisation of its COVID-19 vaccine in India, the…
Mumbai: The debate over Bharat Biotech-manufactured Covaxin continues. A writ plea has been moved before the Bombay High Court seeking…
New Delhi: The Drugs Controller General of India (DCGI) has approved Bharat Biotech's Covaxin for children above the age of…
New Delhi: The All India Drug Action Network (AIDAN) has urged the Drugs Controller General of India (DCGI) to reconsider…
New Delhi: Lauding the final approval of the Drugs Controller General of India (DCGI) on Sunday to two COVID-19 vaccines,…
New Delhi: The new year couldn't have begun on a better note for Pune-based Serum Institute Of India (SII) with…
New Delhi: India has finally got its vaccine against coronavirus. Two vaccines — Pune-based Serum Institute’s Covishield and Bharat Biotech's…
New Delhi: The All India Drug Action Network (AIDAN) has asked the Drugs Controller General of India (DCGI) to reconsider…